Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Tsakonas · SciRah

Researcher profile · Semantic Scholar

G. Tsakonas

Share profile

G. Tsakonas — researcher profile on SciRah

h-index: 17
Works: 62
Citations: 797

Most-cited papers

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
B. Grønberg, K. Killingberg, Ø. Fløtten, O. Brustugun +9 more
2021The Lancet Oncology114 citations Open access
Semantic Scholar
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.
M. Skribek, K. Rounis, S. Afshar, O. Grundberg +4 more
2021European Journal of Cancer102 citations Open access
Semantic Scholar
Management of brain metastasized non-small cell lung cancer (NSCLC) - From local treatment to new systemic therapies.
G. Tsakonas, L. De Petris, S. Ekman
2017Cancer Treatment Reviews51 citations
Semantic Scholar
Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?
R. Califano, F. Gomes, C. Ackermann, S. Rafee +2 more
2019European Journal of Cancer41 citations
Semantic Scholar
Oncogene-addicted non-small cell lung cancer and immunotherapy.
G. Tsakonas, S. Ekman
2018Journal of Thoracic Disease35 citations Open access
Semantic Scholar
PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas
Linda Sooman, S. Ekman, G. Tsakonas, A. Jaiswal +10 more
2014Tumor Biology29 citations
Semantic Scholar
Cancer incidence and mortality patterns in women with anorexia nervosa
Georgios Karamanis, A. Skalkidou, G. Tsakonas, L. Brandt +3 more
2014International Journal of Cancer29 citations
Semantic Scholar
Complications following novel therapies for non‐small cell lung cancer
M. Skribek, K. Rounis, G. Tsakonas, S. Ekman
2022Journal of Internal Medicine27 citations Open access
Semantic Scholar
c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.
G. Tsakonas, J. Botling, P. Micke, C. Rivard +5 more
2019Lung Cancer26 citations
Semantic Scholar
Novel pyrrolo[1,2-a][3.1.6]benzothiadiazocine ring synthesis. Unusual Truce–Smiles type rearrangement of 1-{[1-(2-nitrophenyl)-1H-pyrrol-2-yl]sulfonyl(or sulfinyl)}acetone
A. Kimbaris, J. Cobb, G. Tsakonas, G. Varvounis
200423 citations
Semantic Scholar
An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
G. Tsakonas, R. Lewensohn, J. Botling, C. Ortiz-Villalón +7 more
2020European Journal of Cancer22 citations Open access
Semantic Scholar
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting
M. Skribek, K. Rounis, D. Makrakis, S. Agelaki +4 more
2020Cancers21 citations Open access
Semantic Scholar
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer
Dominika Kaźmierczak, I. J. Eide, R. Gencheva, Yi Lai +8 more
2021Translational Lung Cancer Research20 citations Open access
Semantic Scholar
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.
S. Tendler, V. Grozman, R. Lewensohn, G. Tsakonas +2 more
2018Lung Cancer20 citations
Semantic Scholar
High-dose versus standard dose twice-daily thoracic radiotherapy in limited stage small-cell lung cancer: final survival data, long-term toxicity and relapse patterns in a randomised, open-label, phase II trial.
B. Grønberg, K. Killingberg, Ø. Fløtten, M. Bjaanæs +15 more
2025Journal of Thoracic Oncology18 citations Open access
Semantic Scholar
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?
K. Chatzidionysiou, M. Liapi, G. Tsakonas, I. Gunnarsson +1 more
2020Clinical Rheumatology17 citations Open access
Semantic Scholar
Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)
G. Tsakonas, L. Specht, C. Kristensen, M. Moreno +3 more
2020Cancers17 citations Open access
Semantic Scholar
Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival
Linda Sooman, J. Lennartsson, J. Gullbo, M. Bergqvist +10 more
2013Medical Oncology15 citations
Semantic Scholar
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
G. Tsakonas, V. Tadigotla, S. Chakrabortty, G. Stragliotto +6 more
2023Lung Cancer14 citations Open access
Semantic Scholar
Randomised phase II study with cetuximab in combination with 5-FU and cisplatin or carboplatin versus cetuximab in combination with paclitaxel and carboplatin for treatment of patients with relapsed or metastatic squamous cell carcinoma of the head and neck (CETMET trial).
S. Friesland, G. Tsakonas, C. Kristensen, M. Moren +3 more
201814 citations
Semantic Scholar
Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer
Z. Kosibaty, O. Brustugun, I. J. Zwicky Eide, G. Tsakonas +5 more
2022Cancers12 citations Open access
Semantic Scholar
Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
G. Tsakonas, A. Koulouris, Dominika Kaźmierczak, J. Botling +7 more
2022International Journal of Molecular Sciences12 citations Open access
Semantic Scholar
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy
K. Rounis, M. Skribek, D. Makrakis, L. De Petris +3 more
2021Cancers12 citations Open access
Semantic Scholar
High incidence of thyroid cancer among patients with acromegaly.
Dimitrios Kaldrymidis, G. Papadakis, G. Tsakonas, Philippos Kaldrymidis +7 more
2016Journal of B.U.ON. : official journal of the Balkan Union of Oncology11 citations Open access
Semantic Scholar
Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis
G. Tsakonas, S. Ekman, A. Koulouris, H. Adderley +2 more
2023International Journal of Cancer10 citations Open access
Semantic Scholar
Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer
G. Tsakonas, F. Hellman, M. Gubanski, S. Friesland +4 more
2017Acta oncologica10 citations Open access
Semantic Scholar
Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC).
B. Grønberg, Marianne Aanerud, D. Dumoulin, Jan Nyman +16 more
2025Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures
A. Pipilis, S. Makrygiannis, G. Anagnostou, S. Kaliampakos +4 more
2017Journal of Thrombosis and Thrombolysis9 citations
Semantic Scholar
Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK Inhibition.
G. Tsakonas, V. Grozman, S. Ekman
2020Clinical Lung Cancer8 citations
Semantic Scholar
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study
C. Kamali, G. Tsakonas, P. Hydbring, K. Jatta +5 more
2023Translational Lung Cancer Research7 citations Open access
Semantic Scholar
Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients
A. Alexeyenko, O. Brustugun, I. J. Eide, R. Gencheva +10 more
2021Translational Lung Cancer Research7 citations Open access
Semantic Scholar
Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
A. Pipilis, G. Lazaros, G. Tsakonas, C. Stefanadis
2010Hellenic Journal of Cardiology6 citations
Semantic Scholar
Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report.
M. Skribek, B. Bozóky, G. Tsakonas
2022Lung Cancer5 citations Open access
Semantic Scholar
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
Bjorn H. Henning Gronberg, K. Killingberg, Ø. Fløtten, M. Bjaanæs +15 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC
G. Tsakonas, A. Martín-Bernabé, K. Rounis, Pablo Moreno-Ruiz +7 more
2021Cancers4 citations Open access
Semantic Scholar
ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases
G. Tsakonas, C. Kamali, L. De Petris, S. Friesland +2 more
2020Cancers4 citations Open access
Semantic Scholar
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.
A. Pipilis, S. Kaliambakos, Christos Xenodochidis, G. Tsakonas +2 more
2007Hellenic Journal of Cardiology4 citations
Semantic Scholar
Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar).
O. Grundberg, M. Skribek, S. Swerkersson, Mikael Skorpil +4 more
2024European Journal of Radiology3 citations Open access
Semantic Scholar
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
K. Killingberg, T. Halvorsen, Ø. Fløtten, O. Brustugun +9 more
2022Lung Cancer2 citations Open access
Semantic Scholar
Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc – effects and side effects
V. Grozman, E. Onjukka, P. Wersäll, I. Lax +4 more
2021Acta oncologica2 citations Open access
Semantic Scholar
Novel Pyrrolo[1,2‐a][3.1.6]benzothiadiazocine Ring Synthesis. Unusual Truce—Smiles Type Rearrangement of 1‐{[1‐(2‐Nitrophenyl)‐1H‐pyrrol‐2‐yl]sulfonyl (or sulfinyl)}acetone.
A. Kimbaris, J. Cobb, G. Tsakonas, G. Varvounis
20052 citations
Semantic Scholar
Exhaust Emission Toxicity Assessment for Two Different Modern Gasoline Vehicle Technologies
G. Tsakonas, R. Stamatiou, A. Kontses, A. Lazou +5 more
2023SAE technical paper series1 citations
Semantic Scholar
1299P Effect of fat tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
K. Rounis, D. Makrakis, Alexandros-Pantelis Tsigkas, A. Georgiou +8 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
Risk Factors for Developing Venous Thromboembolism in Patients With Advanced ALK-Rearranged NSCLC
C. Kamali, G. Tsakonas, Rolf Lewensohn, L. Kanter +7 more
2026JTO Clinical and Research Reports0 citations Open access
Semantic Scholar
Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden
A. Koulouris, Ioannis P. Trontzas, I. Vathiotis, M. Livanou +6 more
2026Frontiers in Immunology0 citations Open access
Semantic Scholar
Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery.
A. Koulouris, O. Grundberg, M. Skribek, C. Kamali +3 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Behandlung rheumatischer immunbedingter Nebenwirkungen bei der Krebsimmuntherapie mit Immun-Checkpoint-Inhibitoren – ist es Zeit für einen Paradigmenwechsel?
K. Chatzidionysiou, M. Liapi, G. Tsakonas, I. Gunnarsson +1 more
2022Kompass Autoimmun0 citations Open access
Semantic Scholar
P2.13-03 Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer
A. Alexeyenko, O. Brustugun, I. J. Zwicky Eide, R. Gencheva +10 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP16.02-008 Cerebrospinal Fluid as a Liquid Biopsy for Molecular Characterization of Brain Metastases in Patients With Non-small Cell Lung Cancer
G. Tsakonas, V. Tadigotla, S. Chakrabortty, G. Stragliotto +6 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Biomarkers for CNS metastasis in Non-Small Cell Lung Cancer (NSCLC)
G. Tsakonas
20200 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Ekman×22
Invite
S. Ekman — researcher profile on SciRah
L. De Petris×14
Invite
L. De Petris — researcher profile on SciRah
R. Lewensohn×10
Invite
R. Lewensohn — researcher profile on SciRah
P. Hydbring×10
Invite
P. Hydbring — researcher profile on SciRah

×8

Invite

O. Brustugun — researcher profile on SciRah

Invite

M. Skribek — researcher profile on SciRah

O. Grundberg×7

Invite

O. Grundberg — researcher profile on SciRah

Invite

K. Rounis — researcher profile on SciRah

S. Friesland×6

Invite

S. Friesland — researcher profile on SciRah

K. Killingberg×5

Invite

K. Killingberg — researcher profile on SciRah

Invite

S. Langer — researcher profile on SciRah

Invite

T. Schytte — researcher profile on SciRah